Carcinogenesis and tumor progression of squamos cell carcinoma of the vulva by Emanuels, Arleen Gwendalyn
  
 University of Groningen
Carcinogenesis and tumor progression of squamos cell carcinoma of the vulva
Emanuels, Arleen Gwendalyn
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
1998
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Emanuels, A. G. (1998). Carcinogenesis and tumor progression of squamos cell carcinoma of the vulva.
Groningen: s.n.
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
C h a p t e r  9 123
Clinical and histopathological aspects of vulvar carcinoma
This thesis starts with the clinical impact of prognostic factors and
consequences of treatment to patients with wlvar carcinoma. To illustrate the
problem here we should go back into the history of the treatment of patients
presenting with wlvar carcinoma. In the early part of this century standard
treatment of vulvar cancer comprised radical wlvectomy with bilateral inguino-
femoral lyrnphadenectomy and pelvic ly,rnphadenectomy. This radical surgical
approach markedly increased the survival rates, but postoperative morbidity was
high. Fortunately, a change was made towards more individualized surgical
treatment of patients in the management of wlvar cancer during the eighties.
Major steps in this more tailored treatment were. 'uulva conserving operations,
elimination of pelvic lymphadenectomy, omission of groin node dissection for
patients with stage I tumors with less than lrnm of stromal invasion, unilateral
groin node dissection and use of separate incisions for groin node dissection.
Nowadays, for patients with T1N0-1 vulvar carcinoma wide local excision
instead of vulvectomy is advocated, depending on the conditions of the vulva of
the patients. Still, dissection of groin nodes remains to be standardly performed
when stromal invasion is more than lmm. The issue here is that only a small
group benefits of this approach, because most wlvar carcinoma patients,
attending a physician, present with a tumor that already exceeds I mm of stromal
invasion. So, the starting point here was to look for clinico-pathologic parameters
with which lynph node metastases could be predicted in order to benefit the
majority of the group of patients with wlvar cancer without negatively affecting
survival. Multivariant analysis was perfonned on the routinely used
histopathologic parameters in order to evaluate their value to predict ll,rnph node
metastases. Depth of invasion appeared to be the most predictive parameter of
lymph node metastases followed by differentiation grade. However, even in cases
with 1-3 mm invasion and a well differentiated tumor, the point estimate of the
risk for lymph node metastases was 9%. This probability was too high to refrain
from lymphadenctomy. At this point it was clear that we had to look for other
parameters that could improve our insight in tumor behaviour of squamous cell
carcinoma of the r.ulva.
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Proliferation markers
Cell proliferation is an essential part of growth processes and certain
proteins are specifically expressed during proliferation. These are called tumor
markers and can be used to assess proliferation. In otu study the choice of
proliferation markers was based on certain criteria.
1. the proliferation markers had to be detectable in formalin-fixed paraffrn-
embedded material
2. cells expressing the protein had to be markedly positive to enable
appropriate quantitation
3. an easy and inexpensive detection method was desired.
This had led to our choice of Ki-67 , which is a protein expressed uring the cell
cycle except for the G0- early Gl phase, and Ag-NOR, which are nucleolar
organizer regions involved in cell proliferation. As a reference we used mitotic
index. The finding that Ki-67 index, but not Ag-NOR count was related to mitotic
index has raised questions about the usefulness of Ag-NOR as a proliferation
marker.
In a couple of studies the results of flowcytometry and BrdU-labelling were
correlated with Ag-NOR staining. It was demonstrated that pAg-NOR
(percentage of tumor cells that harbor more than 5 Ag-NORs per cell) correlates
with percentage of cells being in S-phase (proliferative activity), whereas mAg-
NOR (mean number of Ag-NOR dots per cell or nucleus) correlates with amount
of DNA inside the cell (ploidy) (7,9,I0). This could be an explanation why Ag-
NOR staining in our study did not correlate with mitotic index. Nonetheless, we
found no relation between proliferation and lyrnph node metastases, which
indicates that excessive cell proliferation in vulvar carcinoma does not reflect
tumor progression. In the context of the carcinogenesis model of J.Miller and
E.Miller (5), it may be assumed that excessive proliferation of tumor cells reflects
tumor promotion rather than tumor progression.
At the 88th annual meeting of the AACR (apnl 1997) it was postulated by
Kerbel that though it is hardly disputable that oncogenes do have impact on
stirnulating the aberrant proliferation of tumor cells harboring such mutations,
their impact on tumor growth and development - including that of distant
metastases - has probably been overestimated for many types of solid tumor such
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as breast and prostate cancer. The two novel generic fi.nctions of oncogenes
involved in the development and spread of solid tumors, as proposed by Kerbel,
are stimulation or facilitation of angiogenesis and enhancement of tumor cell
survival. Rak et al (13) have demonstrated that mutant ras oncogenes upregulate
VEGF/VPF expression and in another study Rak et al (14) showed that massive
apoptotic death effect in rat intestinal epithelial cells can be aborted by
constitutive or transient expression of a mutant ras oncogene. With respect to
metastasis, oncogenes can also induce or upregulate molecules thought to be
involved in cell motility, migration, invasion and adhesion (i.e. proteases and
adhesion molecules). It follows that the contribution of oncogenes to tumor
progression may reside in stimulating angiogenesis and cell survival (as well as
cell invasion) rather than in their direct contribution to inducing aberrant cell
proliferation.
DNA flow cytometry and tumor ploidy
Measurement of DNA content is a useful method to determine genomic
status of tumor cell populations, but comparison of obtained data is hampered by
discrepancies between the interpretations of DNA histograms. Particularly in
paraffin-embedded material misinterpretation of DNA histograms is caused by the
fact that an admixture of tumor and non-tumor cells is measured. Small deviations
in DNA contents of tumor cells are not easily detected or even remain
undetected. In epithelial tumors anti-cytokeratin labeling enables discrimination
between tumor and non-tumor cells, reducing the chance of misinterpretation of
the DNA histogram of the tumor cell population. We related sidescatter
characteristics of the tumor population to keratin labeling and found these
parameters to be highly correlated. Gating on sidescatter characteristics is easy to
perform and no additional techniques are required. This simple modification
appeared to be a useful tool in distinguishing tumor cells from non-tumor cells.
Moreover, by gating on sidescatter we revealed near diploid and multiploid tumor
cell populations which go undetected by conventional DNA flow cytometric
analysis. Though we could not establish the clinical relevance of this modified
method, the percentage metastasized tumors in the goup of tetraploid and
rnultiploid tumors was higher than in the groups of diploid and aneuploid tumors.
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This could indicate that polyploidisation in tumors reflects a final stage of tumor
progression. Recently, p53 has been implicated in aG2lMphase checkpoint. This
p53-mediated G2À4 checkpoint may account for genomic instability that is
commonly associated with p53 mutation (2) A possible route could be: initiation
of diploid cells leads to promotion, cell division gets disturbed, polyploioisation
occurs aneuploid cell populations will emerge due to chromosomal loss.
Fukasawa et al. (4) demonstrated that mollse embryo fibroblast of p53 null mice
produce abnonnal numbers of centrosomes in a cell (not observed in normal
cells) after a few doublings in cell culture and initiate spindles with three or four
poles. These p53 null cells rapidly become aneuploid at times when cells with
wildtype p53 remain diploid during their passages.
Tumor suppressor genes, proto-oncogenes and HPV
We investigated interrelations between the tumorsuppressor genes p53 and
Rb and proto-oncogenes mdm2 and p2r, and the impact of Hpv on the
expression of these genes. Overexpression of p53 was found to be a late event,
occurring markedly in primary invasive vulvar tumors and their metastases. This
indicates that carcinogenesis of SCC of the wlva is a multistep process in which
mutations of p53 occur late in the phase of tumor progression being closely
related to metastatic potential of the primary tumor. Two inhibitors of
angiogenesis are angiostatin and thrombospondin-l of which the latter is
regulated by wildtype p53. Mutation or loss of wildtype p53 is associated with
loss of TSP-I production and a shift in the balance towards stirnulation of
angiogenesis (3). In this respect it is worth mentioning that tumor angiogenesis i
highly associated with metastasis and tumor dormancy (l l).
Inhibition of p53 functioning is not likely to be due to mdm2 amplification as
our data showed a decline of mdm2 expression with severity of the lesion. A
possible explanation for the decline of mdm2 is that mdm2 is not upregulated by
aberrantly expressed p53 P53 dysfunctioning could neither be ascribed to FIpV
interference, because less than 10oÁ of the cases investigated were FIpV (-16, -
18, -31, -33) positive. of these 10 HPV positive cases 4 showed expression of
p53. If overexpression of p53 found in this series of r,'Lrlvar carcinomas is related
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to mutations in the p53 gene, then these mutations might have been arisen
spontaneously.
In benign lesions FIPV DNA exists as an extachromosomal plasmid. In many
cancers F{PV DNA is integrated into the host chromosome. Integration of the
viral genome, occurring in the EllE2 region, frequently disrupts the E2 ORF,
which encodes transcription regulatory proteins. Loss of these proteins leads to
dysregulation of E6 and E7 expression (16). Moreover, by splicing out an intron
within F,6, an E6* transcript is generated, which appears to be specific for HPV's
related to cervical carcinoma. In the oncogenic I{PV the E7 protein rnay be
encoded by the E6*87 transcript, whereas in the non-oncogenic virus type two
separate transcripts are generated: one forE6 and one forBl (15). InFIPV 6 and
11, the non-oncogenic types, there is no evidence for E6* splicing. Detection of
E6 and E7 transcripts is associated with integration of IIPV DNA into the host
chromosome, whereas detection of El and E2lE4lE5 and the late genes (Ll and
L2) indicates productive F{PV infection. Bóhm et al (1), foturd expression of
F,4lE5 in two of four vulvar carcinomas and expression of Ll only in one case.
He concluded ftat in the cases not expressing E4lE5, F{PV DNA was integrated
in the host chromosome. Park et al. (12) found transcripts of the E6-87 region to
be more abundant than those of the Ll-Lz region in all four lesions. Viral capsid
antigen was detected in a few well-differentiated cells of a warty carcinoma.
IIPV infection might, in first instance, contribute to tumor promotion, but
depending on how seqlrences of the viral DNA (especially the genes encoding for
E6 and E7) are integrated into the host cell genome, this could lead to tumor
progression. In this may lie the clue why IIFV is highly associated with cervical
cancer and not with r,ulvar cancer.
The 10 F{PV positive cases showed expression of Rb in only one case,
which is in concordance with the general theory about l{PV E7 interference with
Rb. Expression of Rb was not related to expression of p53. Overexpression of Rb
may reflect dysregulation of the cell cycle, but the exact route and total impact
are not clear. p}l, a mediator of p53, was also studied, but no relation was found
between p2I and p53 or Rb. It seems that in lulvar carcinomas expression of p2l
is p53 independent. The finding that expression of Rb and p21 is related to
proliferation, but expression of p53 is not, supports the idea that p53 is involved
in the process of tumor progression rather than tumor promotion.
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Though the variables studied here do not contribute to a better prediction of
lymph node metastases, we gained better insight in carcinogenesis and tumor
progression of squamous cell carcinoma of the wlva.
Conclusive remarks and future aspects
The rnajor conclusions that can be drawn frorn this study are:
- neither F{PV infection nor excessive proliferation are relevantly involved in
metastasis of r,ulvar cancer
- prevalence of IIPV infection may be influenced by the patient population
studied
- p53 plays a crucial role in tumor progression of vulvar cancer
- mdrn2 is not upregrrlated by aberrantly expressed p53 in vulvar cancer
- p21 and Rb can be expressed independently of p53 expression in r,ulvar
cancer.
This thesis covers a small part of the total field of carcinogenesis of squamous
cell carcinoma of the wlva. Prediction of lymph node metastases does not appear
to be easy, illustrating the complexity of this multifactorial event. We acquired
more insight about carcinogenesis n general and sqllamous cell carcinoma of the
rulva in particular, which may contribute to future research in this field.
Etiology. The field of interest to many investigators of vulvar cancer was the
prevalence of HPV infection possibly establishing a segregation in a F{PV and a
non-HPV related etiology of wlvar cancer. This is a quite acceptable approach,
considering the major role F{PV infection plays in cervical cancer. A more
fundamental question here would be why HPV is not as highly related to wlvar
cancer as it is to cervical cancer. Somehow epithelial cells of the cervix seem to
be more wlnerable to incorporation of F{PV DNA into the host chromosome than
epithelial cells of the wlva. A study on the prevalence and expression of F{PV
genes in nonnal tissue and sequential lesions like VIN (I-ilI), rnvasive carcinoma
and metastasizing carcinorna rnay clarif' the genetic basis of the development of
different lesions.
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However, even if F{PV infection would be a significant causative factor in
the development of v;lvar cancer, the cause of the majority of r,ulvar cancers, in
particular the keratinizing squamous cell carcinomas, still remain unexplained. As
the latter group occurs mostly in elderly women, it is conceivable that acquired
genetic changes are the main cause of vulvar cancer. In this respect more
ernphasis hould be placed on karyotyping of these tumors. Due to the relative
low prevalence and the genetic complexity of these tumors, cytogenetic reports
considering this tumor are few.
Model of curcinogenesis. The findings in this study regarding regulatory
genes at the protein level does not seem to fit in the actual model of cell cycle
regulation. Most studies contributing to the model are done on translational level
and synchronization of the results should be pursued, before drawing general
conclusions. In this respect p53 mutation analysis at the DNA level of larger
series of vulvar carcinomas is required for proper interpretation of p53 protein
expression. Dysfunctioning of the negative regulators of the cell cycle, like p53,
Rb and p21, will affect expression and functioning of the positve regulators, like
cyclins and cdk's which can be easily studied and mapped. Abnormalities such as
arnplification and reaÍrangement of cyclin Dl have been found in wlvar
carcinoma and cervical cell lines (8). Studies on these genes should be extended
and related to angiogenesis and tumor cell survival as there are indications that
dysregulation of cell cycle genes may facilitates tumor progtession rather than
inducing it.
Advances in detection techniques. The starting point of this study was the
need in the clinique for non-invasive or minimal invasive techniques to predict
lymph node metastases in squamous cell carcinoma of the wlva. Recently a very
elegant study has been done on 10 patients based on detection of the sentinel
lymph node (6). This rninimal invasive method, earlier described for cutaneous
melanoma and breast cancer, involves imagrng by radioactive labeling of the
sentinel node, the first node in the lymphatic basin that receives primary
lymphatic flow. The results aÍe very promising as histopathology of the sentinel
node appears to be representive for the presence of lymph node metastases.
Further development of this technique may in the near future spare patients with a
nesative sentinel node full sroin node dissection.
